MedTrace Logo

Detecting Tumor Specific Amplitude-modulated Frequencies of Cancer Patients

NCT03037840 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2018-10-12

No results posted yet for this study

Summary

Studies have shown that tumor specific amplitude-modulated frequencies of radiofrequency electromagnetic fields that is associated with biofeedback upon exposure to in cancer patients. However, such discovery in other cancer patients are rare. And whether tumor specific frequencies can be found in Asian cancer patients remains unclear. The purpose of this study is to detect the tumor specific frequencies of Asian cancer patients in vivo.

Conditions

  • Neoplasms

Interventions

DEVICE

Low intensity amplitude-modulated RF EMFs

Low intensity amplitude-modulated radiofrequency electromagnetic fields,the carrier frequency is 27.12MHz with a power of about 100mW

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    collaborator OTHER

  • Guangdong 999 Brain Hospital

    collaborator OTHER

  • The 157th Hospital of PLA,China

    collaborator UNKNOWN

  • Southern Medical University, China

    lead OTHER

Principal Investigators

  • Xin Sherman Xuegang, professor · School of Biomedical Engineering,Southern Medical University

  • Cai Linbo, master · Guangdong 999 Brain Hospital

  • Zhu Xiaoxia, PhD · Nanfang Hospital, Southern Medical University

  • Liu Xiantang, bachelor · The 157th Hospital of PLA

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-31
Primary Completion
2019-06-30
Completion
2020-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03037840 on ClinicalTrials.gov